Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development
Crossref DOI link: https://doi.org/10.1007/s40290-017-0209-3
Published Online: 2017-11-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krentz, Andrew J.
Rodriguez-Araujo, Gerardo
License valid from 2017-11-06